Schroder US SMID Opportunities Fund

Schroder US Small and Mid-Cap Opportunities Fund

The 5 star Fund* marked its 10 year milestone in March 2016. Led by Jenny Jones and her experienced team, the Fund is focused on a bottom-up, fundamental and research-based approach to uncovering small and mid-cap opportunities in the US. 

*5 Star Overall Morningstar Rating for Investor Shares out of 376 funds in the Mid-Cap Blend Category as of 6/30/16

Find out more

Broad Tax-Aware Value Bond Fund

Broad Tax-Aware Value Bond Fund

The 5 star Schroder Broad Tax-Aware Value Bond Fund* uses a value-driven approach and seeks to maximize after-tax total return by investing in a portfolio of predominantly investment-grade fixed income securities.

*5 Star Overall Morningstar Rating for Investor Shares out of 306 funds in the Muni National Category as of 6/30/16

Find out more

International Alpha Fund

International Alpha Fund

Schroders 4 star International Alpha Fund* is focused on fundamental research, aimed at delivering strong outperformance over the longer term within the context of a risk management framework.

*4 Star Overall Morningstar Rating for Investor Shares out of 720 funds in the Foreign Large Blend Category as of 6/30/16

Find out more

Economic and Strategy Viewpoint

23AUG 2016

Economic and Strategy Viewpoint - September 2016

Economic and Strategy Viewpoint

23AUG 2016

Economic and Strategy Viewpoint - September 2016

In this month's Olympic-themed Viewpoint, we discuss the race for global growth, the eurozone’s bronze medal performance and the commendable, but not…

READ WHOLE ARTICLE

Fixed Income

23AUG 2016

EM debt: rich or risk?

Fixed Income

23AUG 2016

EM debt: rich or risk?

Historical comparisons are likely to lead investors astray when considering emerging market debt.

READ WHOLE ARTICLE

Economic Views

18AUG 2016

Are negative rates helping? These three charts suggest not

Desperate times have prompted desperate measures. But is the extreme medicine working?

Equities

17AUG 2016

Costly cures: the US drug pricing conundrum

Rising drug prices have been thrust into the limelight by the US presidential nomination campaigns. We look at the implications for the healthcare in…

About Us

Schroders is a world-class asset manager with a unique global heritage of delivering innovative solutions to meet the needs of our clients; many of which include leading corporations, pension funds, endowments and major financial institutions.

Find out more

Twitter